Digital health company Verana Health (San Francisco) has unveiled the Qdata anti-VEGF market tracker. It is their first market tracking Data as a Service (DaaS) product. Excessive amounts of vascular endothelial growth factor (VEGF) can cause abnormal blood vessel growth in the eyes, which, when untreated, can result in vision loss in patients with retinal diseases.…
Verana Health aims to go deep with its real-world data network
The task of extracting health insights from electronic health records (EHRs) has taken longer to materialize than some pundits projected a decade or so ago. But the situation is quickly changing with continued advances in data science, said Sujay Jadhav, CEO of Verana Health (San Francisco), which has created a real-world data network in partnership…
Verana Health raises $150M in Series E funding
Focusing on insights based on real-world data (RWD) related to drug lifecycle and medical practice, Verana Health (San Francisco) has just hauled in $150 million Series E funding. Verana Health’s current fundraising total is $288.8 million, according to CrunchBase. Johnson & Johnson Innovation (JJDC) and Novo Growth led the most recent funding round. Also joining…
9 predictions for pharma in 2022
The pharma industry has been slower to embrace technologies such as AI and digital technology than many less-regulated sectors. The COVID-19 pandemic has changed the equation, forcing pharma companies to become more agile and open-minded in approaching drug discovery and development, including managing evolving clinical trials. In this article, several experts offered their predictions of…
Verana Health to collaborate with Janssen on ophthalmology and urology research
Verana Health (San Francisco), which has expertise in turning clinical data into real-world evidence, announced today that it has inked a research collaboration agreement with Johnson & Johnson‘s Janssen Research & Development. The research with Janssen will have an ophthalmology and urology focus. In the ophthalmology space, Verana Health will analyze the American Academy of…
The top digital health startups in the world
CB Insights’ second annual Digital Health 150 list includes 26 startups seeking to improve drug research and development, an area hard-hit as the COVID-19 pandemic interrupts clinical trials. Drug discovery companies include Healx (rare diseases) and ProteinQure (quantum computing). (Download the full report here.) Get the full story on our sister site Medical Design & Outsourcing. …